GlassScriptPhysician profile
James Gullett
NPI 1811990864
$2,447.24
in general payments reported to CMS, 2019-2025
30 companies · $585 in 2025
The $585 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $71.32 · 2021: $187 · 2022: $547 · 2023: $396 · 2024: $316 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,296.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $397.04 | 2019-2023 | |
| Amgen INC. | $304.06 | 2022-2025 | Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $225.06 | 2019-2023 | |
| Medtronic, INC. | $175.98 | 2023-2025 | Venaseal, V-Loc 180 |
| Astellas Pharma US INC | $134.52 | 2023-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $127.75 | 2019-2024 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Myovant Sciences INC. | $121.96 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $120.84 | 2023-2024 | Myfembree |
| Exact Sciences Corporation | $114.03 | 2023-2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $88.00 | 2023-2025 | Novasure, Myosure Tissue Removal Device, Coolseal Generator |
| Organon LLC | $67.75 | 2022-2025 | Nexplanon |
| Aspira Women'S Health INC | $65.20 | 2022-2024 | Ova1 |
| Pfizer INC. | $54.31 | 2023-2024 | |
| Agile Therapeutics, INC. | $52.30 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $46.27 | 2021-2023 | Gardasil 9 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $41.47 | 2025 | Zurzuvae |
| Medicem INC. | $34.79 | 2022 | |
| Renovia INC | $31.56 | 2019 | |
| Smith+Nephew, INC. | $28.59 | 2024 | Pico 7 |
| Exeltis, USA INC. | $24.77 | 2024 | Slynd |
| Mayne Pharma Commercial LLC | $24.16 | 2023 | |
| Evofem Biosciences, INC. | $22.65 | 2024 | |
| Medline Industries LP | $22.35 | 2024 | |
| Millicent US INC | $21.46 | 2019 | |
| Lupin INC. | $20.67 | 2020 | |
| Supernus Pharmaceuticals, INC. | $18.33 | 2025 | Qelbree |
| Therapeuticsmd, INC. | $16.51 | 2022 | |
| Avion Pharmaceuticals | $15.16 | 2021 | |
| Vertical Pharmaceuticals, LLC | $14.89 | 2019 | |
| Idorsia Pharmaceuticals US INC | $14.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gullett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.